| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | | | | | |
|
PR:000048265 | lymphotoxin-alpha, signal peptide removed form (human) | | | | | |
| |
| |
| |
| |
| |
| |
| | | | | | |
|
PR:000026648 | lymphotoxin-alpha isoform 1, signal peptide removed form | | | | | |
| |
| | | | | | |
|
PR:000026648 | lymphotoxin-alpha isoform 1, signal peptide removed form | | | | | |
| | | | | | |
|
PR:000048265 | lymphotoxin-alpha, signal peptide removed form (human) | | | | | |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
| | | |
|
PR:000002222 | tumor necrosis factor ligand superfamily member 14 | | | | | |
| | | | |
|
PR:O43557 | tumor necrosis factor ligand superfamily member 14 (human) | | | | | |
| | | | | |
|
PR:000065924 | tumor necrosis factor ligand superfamily member 14 deaminated 1 (human) | | | | | |
| | | | | |
|
PR:O43557-1 | tumor necrosis factor ligand superfamily member 14 isoform 1 (human) | | | | | |
| | | | | |
|
PR:O43557-2 | tumor necrosis factor ligand superfamily member 14 isoform 2 (human) | | | | | |
| | | | | |
|
PR:000082240 | tumor necrosis factor ligand superfamily member 14 phosphorylated 1 (human) | | | | | |
| | | | |
|
PR:Q9QYH9 | tumor necrosis factor ligand superfamily member 14 (mouse) | | | | | |
| | | | | |
|
PR:Q9QYH9-1 | tumor necrosis factor ligand superfamily member 14 isoform 1 (mouse) | | | | | |
| | | | |
|
PR:000002353 | tumor necrosis factor ligand superfamily member 14 isoform 1 | | | | | |
| | | | | |
|
PR:O43557-1 | tumor necrosis factor ligand superfamily member 14 isoform 1 (human) | | | | | |
| | | | | |
|
PR:Q9QYH9-1 | tumor necrosis factor ligand superfamily member 14 isoform 1 (mouse) | | | | | |
| | | | |
|
PR:000002354 | tumor necrosis factor ligand superfamily member 14 isoform 2 | | | | | |
| | | | | |
|
PR:O43557-2 | tumor necrosis factor ligand superfamily member 14 isoform 2 (human) | | | | | |
| | | | |
|
PR:000018755 | tumor necrosis factor ligand superfamily member 14 proteolytic cleavage product | | | | | |
| | | |
|
PR:000002223 | tumor necrosis factor ligand superfamily member 15 | | | | | |
| |
| | | | |
|
PR:O95150 | tumor necrosis factor ligand superfamily member 15 (human) | | | | | |
| | | | | |
|
PR:O95150-1 | tumor necrosis factor ligand superfamily member 15 isoform 1 (human) | | | | | |
| | | | | |
|
PR:O95150-2 | tumor necrosis factor ligand superfamily member 15 isoform 2 (human) | | | | | |
| | | | | |
|
PR:O95150-3 | tumor necrosis factor ligand superfamily member 15 isoform 3 (human) | | | | | |
| | | | |
|
PR:Q5UBV8 | tumor necrosis factor ligand superfamily member 15 (mouse) | | | | | |
| | | | | |
|
PR:Q5UBV8-1 | tumor necrosis factor ligand superfamily member 15 isoform 1 (mouse) | | | | | |
| | | | |
|
PR:Q8K3Y7 | tumor necrosis factor ligand superfamily member 15 (rat) | | | | | |
| | | | |
|
PR:000002355 | tumor necrosis factor ligand superfamily member 15 isoform 1 | | | | | |
| | | | | |
|
PR:O95150-1 | tumor necrosis factor ligand superfamily member 15 isoform 1 (human) | | | | | |
| | | | | |
|
PR:Q5UBV8-1 | tumor necrosis factor ligand superfamily member 15 isoform 1 (mouse) | | | | | |
| | | | |
|
PR:000002356 | tumor necrosis factor ligand superfamily member 15 isoform 2 | | | | | |
| | | | | |
|
PR:O95150-2 | tumor necrosis factor ligand superfamily member 15 isoform 2 (human) | | | | | |
| | | | |
|
PR:000002357 | tumor necrosis factor ligand superfamily member 15 isoform 3 | | | | | |
| | | | | |
|
PR:O95150-3 | tumor necrosis factor ligand superfamily member 15 isoform 3 (human) | | | | | |
| | | | |
|
PR:000018756 | tumor necrosis factor ligand superfamily member 15 proteolytic cleavage product | | | | | |
| | | |
|
PR:000000095 | tumor necrosis factor ligand superfamily member 6 | | | | | |
| | | | |
|
PR:P48023 | tumor necrosis factor ligand superfamily member 6 (human) | | | | | |
| | | | | |
|
PR:P48023-1 | tumor necrosis factor ligand superfamily member 6 isoform FasL (human) | | | | | |
| | | | | | |
|
PR:000036458 | tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 (human) | | | | | |
| | | | | | |
|
PR:000036782 | tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (human) | | | | | |
| | | | | | |
|
PR:000036459 | tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form (human) | | | | | |
| | | | | |
|
PR:P48023-2 | tumor necrosis factor ligand superfamily member 6 isoform h2 (human) | | | | | |
| | | | |
|
PR:P41047 | tumor necrosis factor ligand superfamily member 6 (mouse) | | | | | |
| | | | | |
|
PR:P41047-1 | tumor necrosis factor ligand superfamily member 6 isoform FasL (mouse) | | | | | |
| | | | | | |
|
PR:000036783 | tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (mouse) | | | | | |
| | | | | |
|
PR:P41047-2 | tumor necrosis factor ligand superfamily member 6 isoform FasLS (mouse) | | | | | |
| | | | |
|
PR:P36940 | tumor necrosis factor ligand superfamily member 6 (rat) | | | | | |
| | | | |
|
PR:000000277 | tumor necrosis factor ligand superfamily member 6 isoform FasLS | | | | | |
| | | | | |
|
PR:P41047-2 | tumor necrosis factor ligand superfamily member 6 isoform FasLS (mouse) | | | | | |
| | | | |
|
PR:000000276 | tumor necrosis factor ligand superfamily member 6 isoform FasL | | | | | |
| | | | | |
|
PR:P48023-1 | tumor necrosis factor ligand superfamily member 6 isoform FasL (human) | | | | | |
| | | | | | |
|
PR:000036458 | tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 (human) | | | | | |
| | | | | | |
|
PR:000036782 | tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (human) | | | | | |
| | | | | | |
|
PR:000036459 | tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form (human) | | | | | |
| | | | | |
|
PR:P41047-1 | tumor necrosis factor ligand superfamily member 6 isoform FasL (mouse) | | | | | |
| | | | | | |
|
PR:000036783 | tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (mouse) | | | | | |
| | | | | |
|
PR:000000432 | tumor necrosis factor ligand superfamily member 6 isoform FasL glycosylated form | | | | | |
| | | | | | |
|
PR:000000546 | tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 | | | | | |
| | | | | | | |
|
PR:000036458 | tumor necrosis factor ligand superfamily member 6 isoform FasL N-glycosylated 1 (human) | | | | | |
| | | | | |
|
PR:000000278 | tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L | | | | | |
| | | | | | |
|
PR:000036782 | tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (human) | | | | | |
| | | | | | |
|
PR:000036783 | tumor necrosis factor ligand superfamily member 6 isoform FasL sequence variant F273L (mouse) | | | | | |
| | | | | |
|
PR:000000547 | tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form | | | | | |
| | | | | | |
|
PR:000036459 | tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form (human) | | | | | |
| | | | |
|
PR:000018277 | tumor necrosis factor ligand superfamily member 6 proteolytic cleavage product | | | | | |
| | | | | |
|
PR:000000547 | tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form | | | | | |
| | | | | | |
|
PR:000036459 | tumor necrosis factor ligand superfamily member 6 isoform FasL soluble form (human) | | | | | |
| |
| |
| |
| |
| |
| | | | | | |
|
PR:000036504 | tumor necrosis factor isoform 1 cleaved 1 (human) | | | | | |
| | | | | | |
|
PR:000036507 | tumor necrosis factor isoform 1 myristoylated 1 (human) | | | | | |
| | | | | | |
|
PR:000036508 | tumor necrosis factor isoform 1 phosphorylated 1 (human) | | | | | |
| |
| |
| | | | | | |
|
PR:000036505 | tumor necrosis factor isoform 1 cleaved 1 (mouse) | | | | | |
| | | | | | |
|
PR:000036506 | tumor necrosis factor isoform 1 cleaved 2 (mouse) | | | | | |
| |
| |
| |
| | | | | | |
|
PR:000036504 | tumor necrosis factor isoform 1 cleaved 1 (human) | | | | | |
| | | | | | |
|
PR:000036507 | tumor necrosis factor isoform 1 myristoylated 1 (human) | | | | | |
| | | | | | |
|
PR:000036508 | tumor necrosis factor isoform 1 phosphorylated 1 (human) | | | | | |
| |
| | | | | | |
|
PR:000036505 | tumor necrosis factor isoform 1 cleaved 1 (mouse) | | | | | |
| | | | | | |
|
PR:000036506 | tumor necrosis factor isoform 1 cleaved 2 (mouse) | | | | | |
| |
| | | | | | |
|
PR:000036504 | tumor necrosis factor isoform 1 cleaved 1 (human) | | | | | |
| | | | | | |
|
PR:000036505 | tumor necrosis factor isoform 1 cleaved 1 (mouse) | | | | | |
| |
| | | | | | |
|
PR:000036506 | tumor necrosis factor isoform 1 cleaved 2 (mouse) | | | | | |
| | | | | |
|
PR:000000496 | tumor necrosis factor isoform 1 myristoylated form | | | | | |
| | | | | | |
|
PR:000000606 | tumor necrosis factor isoform 1 myristoylated 1 | | | | | |
| | | | | | | |
|
PR:000036507 | tumor necrosis factor isoform 1 myristoylated 1 (human) | | | | | |
| | | | | |
|
PR:000000497 | tumor necrosis factor isoform 1 phosphorylated form | | | | | |
| | | | | | |
|
PR:000000607 | tumor necrosis factor isoform 1 phosphorylated 1 | | | | | |
| | | | | | | |
|
PR:000036508 | tumor necrosis factor isoform 1 phosphorylated 1 (human) | | | | | |
| | | | |
|
PR:000018285 | tumor necrosis factor proteolytic cleavage product | | | | | |
| |
| | | | | | |
|
PR:000036504 | tumor necrosis factor isoform 1 cleaved 1 (human) | | | | | |
| | | | | | |
|
PR:000036505 | tumor necrosis factor isoform 1 cleaved 1 (mouse) | | | | | |
| |
| | | | | | |
|
PR:000036506 | tumor necrosis factor isoform 1 cleaved 2 (mouse) | | | | | |